Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
4 passages
Adults and adolescents aged ≥13 years 2 doses, 4-8 weeks apart 2 doses, 4-8 weeks apart 2 doses, 4-8 weeks apart Recommended for susceptible persons who have close contact with persons at high risk for serious complications: Health-care workers Family contacts of immunocompromised persons No change Recommended for all adolescents and adults without evidence of immunity Should be considered for susceptible persons at high risk for exposure: Persons who live or work in environments in which transmission of VZV is likely (eg, teachers of young children, child care employees, and residents and staff members in institutional settings) Persons who live and work in environments in which transmission can occur (eg, college students, inmates and staff members of correctional institutions, and military personnel) Nonpregnant women of childbearing age International travelers Recommended for susceptible persons at high risk for exposure or transmission: Persons who live or work in environments in which transmission of VZV is likely (eg, teachers of young children, day care employees, and residents and staff members in institutional settings) Persons who live and work in environments in which transmission can occur (eg, college students, inmates and staff members of correctional institutions, and military personnel) Nonpregnant women of childbearing age International travelers Adolescents and adults living in households with children Is desirable for other susceptible adolescents No change
Catch-up vaccination 1 dose recommended for all susceptible children aged 19 months-12 years (ie, those with no history of varicella or vaccination) No change 2nd dose recommended for all persons who received 1 dose previously
HIV*-infected persons Contraindicated 2 doses, 3 months apart 2 doses, 3 months apart Should be considered for asymptomatic or mildly symptomatic HIV-infected children in CDC immunologic and clinical categories N1 or A1 with age-specific CD4+ T-lymphocyte percentages ≥25 percent Should be considered for HIV-infected children with age-specific CD4+ T-lymphocyte, lymphocyte percentages ≥15 percent May be considered for adolescents and adults with CD4 counts ≥200/microL
Vaccination requirements None Recommended for children without evidence of immunity attending child care centers and entering elementary school Recommended for children attending child care centers, students in all grade levels, and persons attending college or other postsecondary educational institutions Should be considered for middle school and junior high school students without other evidence of immunity * Human immunodeficiency virus. Data from: Marin M, Guris DG, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-4):1-40.